UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...
A recent UBS Investor Watch report highlights a deeply divided country in which many view the economy as the main issue this ...
Mexico’s peso is set to strengthen through the first half of next year as investors grow more comfortable with the new ...
Italy's Treasury said on Friday it had picked UBS Europe SE and White & Case Europe LLP as financial and legal advisers for ...
UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.10% of ...
UBS has increased its investment and development of leading FX technology builds notably over the past three years, ...
The latest addition to RBC’s growing wealth operation is a 15-person team that is joining the firm’s Atlanta office.
Novartis (SIX:NOVN), and other stocks could present surprises to investors during the third quarter earnings season, as per analysts at UBS. The analysts flag several key factors that could influence ...
Through the breadth of its market liquidity, product scale and global footprint, UBS has built a strong reputation as the ...
Certara (CERT) stock rises 10% after UBS upgrade to Buy citing strong growth potential in biosimulation software and Model ...